Study details
Enrolling now
Video Education With Result Dependent dIsclosure
Dana-Farber Cancer Institute
NCT IDNCT05225428ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,020
Study length
about 4.1 years
Ages
18+
Locations
1 site in MA
What this study is about
This trial is testing if video education with result dependent disclosure (VERDI) can help make genetic testing more accessible for people at risk of hereditary cancers. The goal is to improve how this type of pre-genetic test education is used in clinical practice.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Genetic Counseling
- 2.Participate in Video Education
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Oncology